Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis

Area of Science:

• Regenerative Medicine
• Orthopedics
• Stem Cell Biology

Background:

• Osteoarthritis (OA) is a degenerative joint disease with limited curative treatments.
• Current OA therapies offer only temporary symptom relief.
• Mesenchymal stem cells (MSCs) show potential for treating cartilage damage and OA.

Purpose of the Study:

• To review the therapeutic potential of MSC-related therapies for osteoarthritis.
• To compare adipose-derived MSCs (AMSCs) with bone marrow-derived MSCs (BMSCs) for OA treatment.
• To explore MSC transplantation, cell-free exosome therapy, and tissue engineering approaches for OA.

Main Methods:

• Review of pre-clinical experiments and clinical trials on MSC therapy for OA.
• Analysis of different MSC sources, including BMSCs and AMSCs.
• Evaluation of various MSC-based therapeutic modalities: transplantation, scaffold-free injection, and exosome therapy.

Main Results:

• AMSCs offer a more accessible stem cell source for OA treatment compared to BMSCs.
• MSC-related therapies, including exosome therapy, demonstrate promise for cartilage repair and OA management.
• Cell-free MSC exosome therapy is highlighted as a potentially safer, cheaper, and more effective treatment modality.

Conclusions:

• MSC-related therapies are a promising avenue for osteoarthritis treatment and joint repair.
• AMSCs and MSC exosome therapy represent advancements in regenerative medicine for OA.
• MSC therapy is predicted to become a routine regenerative medicine approach for OA in the future.